IVERMECTIN SUCCESSFUL in Clinical Trials –> MORE THAN 70% EFFECTIVE in 61 Studies

“Meta analysis using the most serious outcome reported shows 74% and 86% improvement for early treatment and prophylaxis (RR 0.26 [0.16-0.43] and 0.14 [0.08-0.25]), with similar results after exclusion based sensitivity analysis, restriction to peer-reviewed studies, restriction to serious outcomes, and restriction to Randomized Controlled Trials”


more: https://ivmmeta.com/

The improvements are, as seen in the drop in Mortality rates, stunning results!

The protocol is at the Frontline Doctors website:

I-MASK+ Protocol

Translate »